ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICARDO BLONDET VISSEPO M.D.

8133 CALLE CONCORDIA STE 104 EDIFICIO CONCORDIA

Ponce | Puerto Rico | 00717

(787) 842-5315

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 551

$1.22M Total Retail Price of All Prescriptions

Rank: 6 out of 551

1,058 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,058 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

1% of this provider’s 1,058 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 25,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,649 1,364 1 1
GABAPENTIN 1,328 1,029 2 3
METFORMIN HCL 1,275 999 3 2
OMEPRAZOLE 1,076 824 4 7
RANITIDINE HCL 1,024 727 5 8
AMLODIPINE BESYLATE 949 765 6 4
PRAVASTATIN SODIUM 904 751 7 24
LEVOTHYROXINE SODIUM 780 633 8 9
FENOFIBRATE 763 528 9 34
LOSARTAN POTASSIUM 754 574 10 6
LOSARTAN-HYDROCHLOROTHIAZIDE 718 562 11 10
SYNTHROID 677 564 12 11
ATENOLOL 622 494 13 12
ENALAPRIL MALEATE 576 459 14 5
CARVEDILOL 572 497 15 22
HYDROCHLOROTHIAZIDE 410 331 16 15
TRAMADOL HCL-ACETAMINOPHEN 392 333 17 18
GLIPIZIDE 362 295 18 20
GLIMEPIRIDE 354 271 19 16
FUROSEMIDE 350 283 20 13
INSULIN SYRINGE 349 270 21 41
LISINOPRIL 348 315 22 14
ALENDRONATE SODIUM 340 308 23 19
ATORVASTATIN CALCIUM 335 278 24 29
TAMSULOSIN HCL 318 265 25 38
DOXAZOSIN MESYLATE 294 269 26 25
TRAMADOL HCL 292 182 27 32
PANTOPRAZOLE SODIUM 288 205 28 36
ZOLPIDEM TARTRATE 283 260 29 27
METOPROLOL TARTRATE 276 251 30 17
CLOPIDOGREL 260 238 31 30
PLAVIX 254 222 32 33
FAMOTIDINE 251 211 33 31
DONEPEZIL HCL 239 234 34 50
LANTUS 228 153 35 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 220 197 36 59
METOPROLOL SUCCINATE 206 189 37 23
ISOSORBIDE MONONITRATE ER 191 158 38 21
ASPIRIN EC 182 161 39 26
NABUMETONE 178 134 40 37
PREDNISONE 173 127 41 65
WARFARIN SODIUM 160 115 42 46
CILOSTAZOL 159 126 43 64
CIPROFLOXACIN HCL 158 125 44 54
JANUVIA 153 127 45 87
ZETIA 144 121 46 69
NAPROXEN SODIUM 143 113 47 137
DIGOXIN 139 115 48 44
LEVOXYL 137 124 49 40
RAMIPRIL 135 107 50 53
EVISTA 135 116 50 52
ALLOPURINOL 135 86 50 84
AMOX TR-POTASSIUM CLAVULANATE 134 101 53 113
AZITHROMYCIN 132 102 54 55
MAXIMUM D3 130 117 55 103
OXYCODONE-ACETAMINOPHEN 128 57 S2 56 102
LANSOPRAZOLE 125 95 57 72
NAMENDA 123 123 58 94
SERTRALINE HCL 116 106 59 43
CAPTOPRIL 110 84 60 63
PREDNISOLONE 110 90 60 118
SULINDAC 107 75 62 78
MECLIZINE HCL 104 78 63 56
NOVOLIN 70-30 101 81 64 172
VERAPAMIL ER 100 87 65 39
SURE COMFORT 95 81 66 74
LEVOCETIRIZINE DIHYDROCHLORIDE 93 79 67 195
IRBESARTAN 93 87 67 51
JANUMET 93 63 67 109
FOSINOPRIL SODIUM 92 70 70 89
CITALOPRAM HBR 92 79 70 122
PROPRANOLOL HCL 87 82 72 139
AVAPRO 85 71 73 83
LEVETIRACETAM 83 71 74 182
NOVOLOG 83 70 74 211
COUMADIN 82 78 76 88
CLOTRIMAZOLE-BETAMETHASONE 80 67 77 49
DIOVAN HCT 79 59 78 71
HUMULIN N 79 69 78 47
GLIPIZIDE ER 77 58 80 85
CLONIDINE HCL 76 48 81 60
PAROXETINE HCL 75 56 82 77
OXYBUTYNIN CHLORIDE ER 75 60 82 216
GLYBURIDE 75 70 R 82 70
CRESTOR 74 66 85 62
HUMULIN 70-30 72 52 86 35
ENDOCET 71 45 S2 87 157
CARTIA XT 70 63 88 146
PENTOXIFYLLINE 69 56 89 73
THEOPHYLLINE ANHYDROUS 67 48 90 125
FINASTERIDE 66 65 91 82
HUMALOG MIX 75-25 66 48 91 110
FLUTICASONE PROPIONATE 63 36 93 66
DILTIAZEM 24HR CD 63 62 93 98
ADVAIR DISKUS 62 43 95 97
TRIAMTERENE-HCTZ 61 45 96 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 53 97 119
CYCLOBENZAPRINE HCL 60 20 R 97 184
POLYETHYLENE GLYCOL 3350 60 55 97 192
CYMBALTA 58 50 100 105
HUMALOG 57 28 101 101
DESONIDE 56 36 102 233
SINGULAIR 56 25 102 58
AMITRIPTYLINE HCL 56 40 R 102 96
DIOVAN 56 44 102 57
QUINAPRIL HCL 56 50 102 104
MUPIROCIN 55 45 107 185
KOMBIGLYZE XR 55 35 107 231
LATANOPROST 53 35 109 121
LYRICA 53 22 109 86
SPIRIVA 52 41 111 133
NITROGLYCERIN PATCH 51 49 112 237
CICLOPIROX 51 30 112 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.